4.8 Article

A positive role for Myc in TGFβ-induced Snail transcription and epithelial-to-mesenchymal transition

期刊

ONCOGENE
卷 28, 期 3, 页码 422-430

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.395

关键词

TGF beta; Myc; Snail; EMT

资金

  1. Association for Cancer Research (AIRC)
  2. International Association for Cancer Research (AICR)

向作者/读者索取更多资源

Myc and transforming growth factor-beta (TGF beta) signaling are mutually antagonistic, that is Myc suppresses the activation of TGF beta-induced genes, whereas TGF beta represses c-myc transcription. Here, we report a positive role for Myc in the TGF beta response, consisting in the induction of an epithelial-to-mesenchymal transition (EMT) and the activation of the EMT-associated gene Snail. Knockdown of either Myc or the TGF beta effectors SMAD3/4 in epithelial cells eliminated Snail induction by TGF beta. Both Myc and SMAD complexes targeted the Snail promoter in vivo, DNA binding occurring in a mutually independent manner. Myc was bound prior to TGF beta treatment, and was required for rapid Snail activation upon SMAD binding induced by TGF beta. On the other hand, c-myc downregulation by TGF beta was a slower event, occurring after Snail induction. The response of Snail to another cytokine, hepatocyte growth factor (HGF), also depended on Myc and SMAD4. Thus, contrary to their antagonistic effects on Cip1 and INK4b, Myc and SMADs cooperate in signal-dependent activation of Snail in epithelial cells. Although Myc also targeted the Snail promoter in serum-stimulated fibroblasts, it was dispensable for its activation in these conditions, further illustrating that the action of Myc in transcriptional regulation is context-dependent. Our findings suggest that Myc and TGF beta signaling may cooperate in promoting EMT and metastasis in carcinomas.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value

Angela Santoro, Thalia Vlachou, Lucilla Luzi, Giorgio Melloni, Luca Mazzarella, Errico D'Elia, Xieraili Aobuli, Cristina Elisabetta Pasi, Linsey Reavie, Paola Bonetti, Simona Punzi, Lucia Casoli, Arianna Sabo, Maria Cristina Moroni, Gaetano Ivan Dellino, Bruno Amati, Francesco Nicassio, Luisa Lanfrancone, Pier Giuseppe Pelicci

CELL REPORTS (2019)

Article Biochemistry & Molecular Biology

An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation

Alessandra Tesi, Stefano de Pretis, Mattia Furlan, Marco Filipuzzi, Marco J. Morelli, Adrian Andronache, Mirko Doni, Alessandro Verrecchia, Mattia Pelizzola, Bruno Amati, Arianna Sabo

EMBO REPORTS (2019)

Article Gastroenterology & Hepatology

Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz

Andrea Bisso, Marco Filipuzzi, Gianni Paolo Gamarra Figueroa, Giulia Brumana, Francesca Biagioni, Mirko Doni, Giorgia Ceccotti, Nina Tanaskovic, Marco Jacopo Morelli, Vera Pendino, Fulvio Chiacchiera, Diego Pasini, Daniela Olivero, Stefano Campaner, Arianna Sabo, Bruno Amati

HEPATOLOGY (2020)

Article Multidisciplinary Sciences

Reactivation of Myc transcription in the mouse heart unlocks its proliferative capacity

Megan J. Bywater, Deborah L. Burkhart, Jasmin Straube, Arianna Sabo, Vera Pendino, James E. Hudson, Gregory A. Quaife-Ryan, Enzo R. Porrello, James Rae, Robert G. Parton, Theresia R. Kress, Bruno Amati, Trevor D. Littlewood, Gerard Evan, Catherine H. Wilson

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription

Paola Pellanda, Mattia Dalsass, Marco Filipuzzi, Alessia Loffreda, Alessandro Verrecchia, Virginia Castillo Cano, Hugo Thabussot, Mirko Doni, Marco J. Morelli, Laura Soucek, Theresia Kress, Davide Mazza, Marina Mapelli, Marie-Eve Beaulieu, Bruno Amati, Arianna Sabo

Summary: Eukaryotic transcription factors have both specific DNA sequence motif recognition and non-specific DNA-binding activity. Non-specific DNA binding is essential for engaging with genomic regulatory regions, while sequence recognition contributes to transcriptional activation by stabilizing Myc onto DNA and unexpectedly promoting its transcriptional activity. The seemingly pervasive genome interaction profiles detected by ChIP-seq actually encompass diverse DNA-binding modes driving defined, sequence-dependent transcriptional responses.

EMBO JOURNAL (2021)

Article Oncology

Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma

Giulio Donati, Micol Rava, Marco Filipuzzi, Paola Nicoli, Laura Cassina, Alessandro Verrecchia, Mirko Doni, Simona Rodighiero, Federica Parodi, Alessandra Boletta, Christopher P. Vellano, Joseph R. Marszalek, Giulio F. Draetta, Bruno Amati

Summary: MYC activity is closely correlated with gene expression signatures related to oxidative phosphorylation in DLBCL, sensitizing B cells to the ETC complex I inhibitor IACS-010759. The combination of BCL2 inhibitor venetoclax and IACS-010759 showed synergy in DHL with concurrent activation of MYC and BCL2, while in BCL2-negative lymphoma cells, the Mcl-1 inhibitor S63845 potentiated killing by IACS-010759. This suggests a novel therapeutic approach against aggressive, MYC-associated DLBCL variants.

MOLECULAR ONCOLOGY (2022)

Article Multidisciplinary Sciences

Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs

Chiara Ronchini, Sara Gandini, Sebastiano Pasqualato, Luca Mazzarella, Federica Facciotti, Marina Mapelli, Gianmaria Frige', Rita Passerini, Luca Pase, Silvio Capizzi, Fabrizio Mastrilli, Roberto Orecchia, Gioacchino Natoli, Pier Giuseppe Pelicci

Summary: In this study, we found that the probability of infection post-vaccination is significantly lower compared to natural infection, and the duration of infection is shorter. These findings are negatively correlated with circulating antibody levels.

PLOS ONE (2022)

Article Biology

Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis

Nina Tanaskovic, Mattia Dalsass, Marco Filipuzzi, Giorgia Ceccotti, Alessandro Verrecchia, Paola Nicoli, Mirko Doni, Daniela Olivero, Diego Pasini, Haruhiko Koseki, Arianna Sabo, Andrea Bisso, Bruno Amati

Summary: Loss of Mga and PRC1.6 has no significant impact on Myc-induced lymphomagenesis in transgenic mice, but loss of Pcgf6 accelerates tumor formation. This suggests an unexpected tumor suppressor activity of Pcgf6 independent of Mga and PRC1.6.

LIFE SCIENCE ALLIANCE (2022)

Review Oncology

MYC and therapy resistance in cancer: risks and opportunities

Giulio Donati, Bruno Amati

Summary: The MYC transcription factor plays a crucial role in tumor progression and therapeutic responses. Overexpression of MYC can lead to therapy resistance and create specific vulnerabilities in cancer cells that can be targeted by novel anticancer drugs.

MOLECULAR ONCOLOGY (2022)

Article Medicine, Research & Experimental

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma

Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati

Summary: MYC is a key driver in multiple tumor types and can be targeted by drugs that suppress mitochondrial respiration. In this study, the mechanistic basis for the lethal interaction between MYC and respiratory complex I inhibitor IACS-010759 was unraveled. It was found that high-dose ascorbate synergized with IACS-010759 to kill MYC-overexpressing cells and improved therapeutic outcomes in B-cell lymphoma xenografts.

EMBO MOLECULAR MEDICINE (2023)

暂无数据